open access
Vol 70, No 2 (2019)
Letter to Readers
Submitted: 2019-04-30
Accepted: 2019-04-30
Get Citation
Letter do Readers [List do Czytelników]
DOI: 10.5603/ep.64165
·
Endokrynol Pol 2019;70(2):1-2.
open access
Vol 70, No 2 (2019)
Letter to Readers
Submitted: 2019-04-30
Accepted: 2019-04-30
Abstract
Not available
Abstract
Not available
Get Citation
About this articleTitle
Letter do Readers [List do Czytelników]
Journal
Issue
Article type
Letter to Readers
Pages
1-2
Page views
295
Article views/downloads
321
DOI
10.5603/ep.64165
Bibliographic record
Endokrynol Pol 2019;70(2):1-2.
Authors
Beta Kos-Kudła
References (4)- Pasquali R, Zanotti L, Fanelli F, et al. Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective. J Clin Endocrinol Metab. 2016; 101(5): 2013–2022.
- Rogowicz-Frontczak A, Majchrzak A, Zozulińska-Ziółkiewicz D. Insulinooporność w chorobach endokrynnych — sposoby terapii. Endokrynologia Polska. 2017; 68(3): 334–351.
- Anagnostis P, Tarlatzis BC, Kauffman RP. Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences. Metabolism. 2018; 86: 33–43.
- Press MJ, Howe R, Schoenbaum M, et al. Medicare Payment for Behavioral Health Integration. N Engl J Med. 2017; 376(5): 405–407.
